Trial Profile
Effectiveness and Safety of INGN 201 in Combination With Chemotherapy Versus Chemotherapy Alone
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 27 Feb 2017
Price :
$35
*
At a glance
- Drugs Contusugene ladenovec (Primary) ; Cisplatin; Fluorouracil
- Indications Head and neck cancer; Squamous cell cancer
- Focus Registrational; Therapeutic Use
- Sponsors Introgen Therapeutics
- 17 Mar 2008 Interim results will be presented at AACR 2008.
- 05 Aug 2005 New trial record.